Investors Bet Billions on AI Research Labs With No Products Yet

Venture capitalists are placing massive bets on artificial intelligence research labs that have raised tens of billions of dollars without releasing commercial products, reflecting a fundamental shift in how the industry funds breakthrough AI development. The trend centers on what the industry calls "neolabs"—pre-revenue startups focused on long-term AI breakthroughs, founded by elite researchers from Google DeepMind, OpenAI, Stanford, and Meta. According to tracker data, 99 such labs have disclosed at least $35 billion in capital raises with combined reported valuations of $187 billion, yet only 16 of these companies disclose any revenue at all.